Publications by authors named "Lluis Force"

Claim this Profile
I
Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial.
Jose M Miro, Ferran Torres, Christian Manzardo, Eva Bonfill, Adrià Curran, Lluis Force

Clin Microbiol Infect· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and durability of dual antiretroviral therapy in HIV-infected patients.
Laia Pérez-Cordón, Azhara Sánchez, Sergio Marin, Lluis Force, Mateu Serra-Prat

Eur J Hosp Pharm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
Daniel K Nomah, Juliana Reyes-Urueña, Yesika Díaz, Sergio Moreno, Jordi Aceiton, Lluís Force

Lancet HIV· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early tocilizumab treatment could improve survival among COVID-19 patients.
Lluis Campins, Ramon Boixeda, Laia Perez-Cordon, Raquel Aranega, Carlos Lopera, Lluis Force

Clin Exp Rheumatol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Qian Chen, Celia Perales, María Eugenia Soria, Damir García-Cehic, Josep Gregori, Lluís Force

Antiviral Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the HIV undiagnosed population in Catalonia, Spain: descriptive and comparative data analysis to identify differences in MSM stratified by migrant and Spanish-born population.
Juliana Maria Reyes-Urueña, Colin N J Campbell, Núria Vives, Anna Esteve, Juan Ambrosioni, Lluis Force

BMJ Open· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant.
Juan Berenguer, Inmaculada Jarrín, Leire Pérez-Latorre, Víctor Hontañón, María J Vivancos, Lluis Force

Open Forum Infect Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of influenza vaccination on the prognosis of hospitalized influenza patients.
Itziar Casado, Angela Domínguez, Diana Toledo, Judith Chamorro, Lluis Force

Expert Rev Vaccines· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain.
Àngela Domínguez, Núria Soldevila, Diana Toledo, Pere Godoy, Jesús Castilla, Lluís Force

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.
David Nicolás, Anna Esteve, Anna Cuadros, Colin N J Campbell, Cristina Tural, Lluis Force

Clin Infect Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The continuum of HIV care in Catalonia.
Colin N J Campbell, Juan Ambrosioni, Jose M Miro, Anna Esteve, Jordi Casabona, Lluis Force

AIDS Care· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences.
José Ramón Santos, José Luis Blanco, Mar Masiá, Félix Gutiérrez, María Jesús Pérez-Elías, Lluis Force

J Antimicrob Chemother· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.
Frederik N Engsig, Robert Zangerle, Olga Katsarou, Francois Dabis, Peter Reiss, Lluís Force

Clin Infect Dis· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

AIDS· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Eugenia Negredo, Oscar Miró, Benjamí Rodríguez-Santiago, Glòria Garrabou, Carla Estany, Lluís Force

Clin Infect Dis· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients.
Daniel Podzamczer, Montserrat Olmo, Jose Sanz, Vicente Boix, Eugenia Negredo, Lluis Force

J Acquir Immune Defic Syndr· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional status as a risk factor for mortality in very elderly patients with pneumonia.
Mateu Cabré, Mateu Serra-Prat, Lluís Force, Elisabet Palomera, Roman Pallarés

Med Clin (Barc)· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
Angeles Jaén, Anna Esteve, Josep M Miró, Cristina Tural, Alexandra Montoliu, Lluis Force

J Acquir Immune Defic Syndr· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.
Daniel Fuster, Jaime A Huertas, Guadalupe Gómez, Ricard Solà, Juan González García, Lluís Force

Antivir Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor response to hepatitis C virus (HCV) therapy in HIV- and HCV-coinfected patients is not due to lower adherence to treatment.
Ricard Solà, Josep Antón Galeras, Silvia Montoliu, Cristina Tural, Lluis Force

AIDS Res Hum Retroviruses· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.
Anna Bonjoch, Roger Paredes, Pere Domingo, Manel Cervantes, Enric Pedrol, Lluís Force

AIDS Res Hum Retroviruses· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyanamide-induced aplastic anemia.
Elena Ballarín, Luisa Ibáñez, José-Angel Hernández, Lluís Force, Joan-Ramon Laporte

Eur J Clin Pharmacol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project].
Angeles Jaén, Jordi Casabona, Anna Esteve, Jose M Miró, Cristina Tural, Lluís Force

Med Clin (Barc)· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
Esteban Martínez, Juan A Arnaiz, Daniel Podzamczer, David Dalmau, Esteban Ribera, Lluis Force

N Engl J Med· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Recommendations for non-occupational postexposure HIV prophylaxis. Spanish Working Group on Non-Occupational Postexposure HIV Prophylaxis of the Catalonian Center for Epidemiological Studies on AIDS and the AIDS Study Group].
Jesús Almeda, Jordi Casabona, Alejandro Allepuz, Felipe García-Alcaide, Jorge del Romero, Lluís Force

Enferm Infecc Microbiol Clin· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis